The question gets asked often enough that it deserves a direct answer rather than reassurance. Fibromyalgia is a recognised diagnosis in the ICD and has been for decades. What made it contested was not the absence of suffering but the absence of a visible lesion.
What "no visible cause" actually meant
Standard investigations look at blood markers, joints and large nerve fibres. Fibromyalgia does not disturb any of those, so the tests come back clean. For a long time that was read as evidence of nothing being wrong, rather than as evidence that the wrong tissue was being examined.
What has been measured since
Small-fibre abnormalities have been documented in a substantial subset of patients. Quantitative sensory testing shows reproducible differences in pain processing. And imaging work since 2021 has found measurably thicker and stiffer connective tissue in fibromyalgia patients, with stiffness tracking reported pain.
Why the debate persisted anyway
Partly inertia, partly that the condition is diagnosed by symptom criteria rather than a test — which feels less solid to clinicians trained on biomarkers. A diagnosis made by careful history is still a diagnosis; migraine works the same way.
The honest position
Fibromyalgia is real, measurable in several ways, and still not fully explained. Anyone claiming the mechanism is settled is ahead of the evidence, in either direction.
This article is for information only and is not medical advice.
